midazolam has been researched along with rifamycins in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Gonzalez, FJ; Guo, GL; Idle, JR; Krausz, KW; Ma, X; Shah, YM; Wang, T | 1 |
| Bettenhausen, DK; Connolly, M; Forbes, WP; Pentikis, HS; Trapnell, CB | 1 |
1 trial(s) available for midazolam and rifamycins
| Article | Year |
|---|---|
The effect of multiple-dose, oral rifaximin on the pharmacokinetics of intravenous and oral midazolam in healthy volunteers.
Topics: Administration, Oral; Adolescent; Adult; Anti-Anxiety Agents; Anti-Infective Agents; Area Under Curve; Biological Availability; Cross-Over Studies; Cytochrome P-450 CYP3A; Disorders of Excessive Somnolence; Dose-Response Relationship, Drug; Female; Half-Life; Humans; Infusions, Intravenous; Injections, Intravenous; Intestines; Liver; Male; Midazolam; Middle Aged; Rifamycins; Rifaximin | 2007 |
1 other study(ies) available for midazolam and rifamycins
| Article | Year |
|---|---|
Rifaximin is a gut-specific human pregnane X receptor activator.
Topics: Animals; Cytochrome P-450 CYP3A; Cytochrome P-450 Enzyme System; Dose-Response Relationship, Drug; Gastrointestinal Agents; Humans; Intestinal Mucosa; Intestines; Male; Mice; Midazolam; Pregnane X Receptor; Receptors, Steroid; Rifampin; Rifamycins; Rifaximin | 2007 |